HydraSolve - Gentle liposuction for Fat Transfers

HydraSolve’s Tissue Liquefaction Technology (TLT)

Tissue Liquefaction Technology, TLT, is a new way of delivering energy which allows relatively low levels of both thermal and mechanical energy to be delivered to a surgical target. TLT works well as a surgical energy source whenever the target tissue requires less energy to be liquefied than the adjacent non-target tissue. That is precisely the nature of the surgical field in fat harvesting, and is consistent with our earlier adaptation in cataract surgery. TLT has clinically proven its target tissue specific liquefaction capability in cataract surgery and in lipoplasty.

 

Cataract Surgery – The First Application of Tissue Liquefaction Technology

In 2003, Alcon launched the AquaLase® Liquefaction Device as a precision cataract removal system (AquaLase® is a modality on Alcon’s Infiniti Vision System). After tens of thousands of treatments around the world, the AquaLase® system has established Tissue Liquefaction as a method that allows surgeons to remove cataracts with target tissue specificity. A total of 18 articles have been published in peer-reviewed ophthalmic journals documenting the safety and effectiveness of TLT in cataract surgery in 687 patients. When the AquaLase® handpiece tip was inside the eye actively liquefying and aspirating the cataract: not a single complication was reported in any of those 687cases. That’s clinical proof of the remarkable benefit TLT’s target tissue specificity can provide in a surgical procedure. Articles profiling five randomized prospective clinical studies of AquaLase® are listed below, as an example of the peer reviewed ophthalmic literature:

Cornea, 25(9):1043-1045, October 2006, Randomized, Double-Masked Clinical Trial Evaluating Corneal Endothelial Cell Loss After Cataract Extraction and Introcular Lens Implantation Fluid-Based System Versus Ultrasound Phacoemulsification. Sandoval, HP et al

American Journal of Ophthalmology, 148(3):390-395, 2009, Three-Year Follow-up of Posterior Capsule Opacification After AquaLase® and NeoSoniX Phacoemulsification. Nekolova, J et al

Journal of Cataract and Refractive Surgery, 34: 991-995, June 2008, Prospective Randomized Controlled Trial to Compare the Effect on the Macula of AquaLase® Liquefaction and Ultrasound Phacoemulsification Cataract Surgery. Barsam, A et al.

Journal of Cataract and Refractive Surgery, 34:377-382, March 2008, Comparison of the Effect of AquaLase® and NeoSonix Phacoemulsification on the Corneal Endothelium. Jiraskova, N et al.

Cornea, 29(3):247-250, 2010, The Effect of Aqualase and Phacoemulsification on the Corneal Endothelium. Hu, V et al